OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults
Kirsten E. Smith, Leigh V. Panlilio, Jeffrey D. Feldman, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2353401-e2353401
Open Access | Times Cited: 14
Kirsten E. Smith, Leigh V. Panlilio, Jeffrey D. Feldman, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2353401-e2353401
Open Access | Times Cited: 14
Showing 14 citing articles:
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency
Jeffrey M. Rogers, Stephanie T. Weiss, David H. Epstein, et al.
Drug and Alcohol Dependence (2024) Vol. 260, pp. 111329-111329
Closed Access | Times Cited: 9
Jeffrey M. Rogers, Stephanie T. Weiss, David H. Epstein, et al.
Drug and Alcohol Dependence (2024) Vol. 260, pp. 111329-111329
Closed Access | Times Cited: 9
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use
Katherine Hill, Jeffrey M. Rogers, Oliver Grundmann, et al.
The American Journal of Drug and Alcohol Abuse (2025), pp. 1-13
Open Access
Katherine Hill, Jeffrey M. Rogers, Oliver Grundmann, et al.
The American Journal of Drug and Alcohol Abuse (2025), pp. 1-13
Open Access
Prevalence and Use Patterns of Kratom ( Mitragyna speciosa Korth.) in a US Nationally Representative Sample
Oliver Grundmann, MeShell Green, Erin C. Berthold, et al.
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access
Oliver Grundmann, MeShell Green, Erin C. Berthold, et al.
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study
C. Austin Zamarripa, Tory R. Spindle, Leigh V. Panlilio, et al.
Traffic Injury Prevention (2024) Vol. 25, Iss. 4, pp. 594-603
Open Access | Times Cited: 3
C. Austin Zamarripa, Tory R. Spindle, Leigh V. Panlilio, et al.
Traffic Injury Prevention (2024) Vol. 25, Iss. 4, pp. 594-603
Open Access | Times Cited: 3
Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report
Oliver Grundmann, Kirsten E Smith, Walter C. Prozialeck, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Oliver Grundmann, Kirsten E Smith, Walter C. Prozialeck, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content
Kirsten E. Smith, Leigh V. Panlilio, Abhisheak Sharma, et al.
Drug and Alcohol Dependence (2024) Vol. 264, pp. 112460-112460
Open Access | Times Cited: 1
Kirsten E. Smith, Leigh V. Panlilio, Abhisheak Sharma, et al.
Drug and Alcohol Dependence (2024) Vol. 264, pp. 112460-112460
Open Access | Times Cited: 1
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
Kirsten E. Smith, David H. Epstein, Stephanie T. Weiss
Current Psychiatry Reports (2024) Vol. 26, Iss. 9, pp. 487-496
Open Access | Times Cited: 1
Kirsten E. Smith, David H. Epstein, Stephanie T. Weiss
Current Psychiatry Reports (2024) Vol. 26, Iss. 9, pp. 487-496
Open Access | Times Cited: 1
Kratom (Mitragyna Speciosa) Use for Self-Management of Pain: Insights from Cross-Sectional and Ecological Momentary Assessment Data
Chung Jung Mun, Leigh V. Panlilio, Kelly E. Dunn, et al.
Journal of Pain (2024) Vol. 26, pp. 104726-104726
Closed Access
Chung Jung Mun, Leigh V. Panlilio, Kelly E. Dunn, et al.
Journal of Pain (2024) Vol. 26, pp. 104726-104726
Closed Access
Naturally based mystic drugs
Francesc A. Esteve‐Turrillas
Comprehensive analytical chemistry (2024)
Closed Access
Francesc A. Esteve‐Turrillas
Comprehensive analytical chemistry (2024)
Closed Access
Kratom Alkaloids for the Treatment of Alcohol Use Disorder
Joydip Das
ACS Chemical Neuroscience (2024)
Closed Access
Joydip Das
ACS Chemical Neuroscience (2024)
Closed Access
The rise of novel, semi‐synthetic 7‐hydroxymitragnine products
Kirsten E. Smith, Edward W. Boyer, Oliver Grundmann, et al.
Addiction (2024)
Closed Access
Kirsten E. Smith, Edward W. Boyer, Oliver Grundmann, et al.
Addiction (2024)
Closed Access
An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans
Elisabeth Prevete, Eef L. Theunissen, Kim P. C. Kuypers, et al.
Psychopharmacology (2024)
Open Access
Elisabeth Prevete, Eef L. Theunissen, Kim P. C. Kuypers, et al.
Psychopharmacology (2024)
Open Access
